APOPTOTIC AND PROLIFERATIVE ACTIVITY IN OVARIAN BENIGN,BORDERLINE AND MALIGNANT TUMORS

被引:0
|
作者
刘爱军
陈乐真
颜婉嫦
邱玮璇
赵昀
张雅贤
机构
关键词
Ki-67; M30; topoisomerase IIα; ovarian epithelial tumor;
D O I
暂无
中图分类号
R730.2 [肿瘤病理学、病因学];
学科分类号
100214 ;
摘要
Objective.To determine the apoptotic and proliferative activities in various ovarian epithelial tumors.Methods.Formalin-fixed,paraffin-embedded tissues of 86ovarian epithelial tu mors,including 52adenocarcino-mas,23borderline tumors and 11cystadenomas,were retrieved.Apoptoti c(AI )and proliferative(PI )index were estimated using the monoclonal antibodies:M30,Ki-67and Ki-S1in t hese tumors.Quantitative assess-ment of AI and PI was estimated by calc ulating the percentage of positive c ells among no less than 1000tumor cells.Results.Statistically significant differe nce in AI was found between benign and borderline tumors or carcino-mas(P=0.028,0.001,respectively).Significant differences in PI,as a ssessed by both Ki-67and topo IIα,were demonstrated between carcinom as and benign or borderline tumors(both P<0.001).Benign tumors had both low PI and AI;borderline tumors had lower PI but higher AI,while aden ocarcinomas had both high prolifera-tive and high apoptotic rates.Among borderline tumors,serous tumors had significantly lower AI and higher PI than mucinous ones.Conclusions.The results suggest that apoptotic a nd proliferative activities play im portant roles in the pathogene-sis and development of ovarian borderline and malignant tumors.The high apoptotic rate in borderline tumor m ay explain its relatively indolent beh avior while the high proliferative r ate in carcinomas tends to explain its aggres-sive behavior.
引用
收藏
页码:106 / 111
页数:6
相关论文
共 50 条
  • [41] Quantitative dynamic contrast-enhanced MR imaging for differentiating benign, borderline, and malignant ovarian tumors
    Hai-ming Li
    Feng Feng
    Jin-wei Qiang
    Guo-fu Zhang
    Shu-hui Zhao
    Feng-hua Ma
    Yong-ai Li
    Wei-yong Gu
    [J]. Abdominal Radiology, 2018, 43 : 3132 - 3141
  • [42] QUANTITATION OF BORDERLINE AND MALIGNANT MUCINOUS OVARIAN-TUMORS
    BAAK, JPA
    BLANCO, AA
    KURVER, PHJ
    LANGLEY, FA
    BOON, ME
    LINDEMAN, J
    OVERDIEP, SH
    NIEUWLAAT, A
    BREKELMANS, E
    [J]. HISTOPATHOLOGY, 1981, 5 (04) : 353 - 360
  • [44] THE BORDERLAND BETWEEN BENIGN AND MALIGNANT SURFACE EPITHELIAL OVARIAN-TUMORS - CURRENT CONTROVERSY OVER THE NATURE AND NOMENCLATURE OF BORDERLINE OVARIAN-TUMORS
    LAWRENCE, WD
    [J]. CANCER, 1995, 76 (10) : 2138 - 2142
  • [45] NEU PROTEIN OVEREXPRESSION IN BENIGN, BORDERLINE, AND MALIGNANT OVARIAN NEOPLASMS
    KACINSKI, BM
    MAYER, AG
    KING, BL
    CARTER, D
    CHAMBERS, SK
    [J]. GYNECOLOGIC ONCOLOGY, 1992, 44 (03) : 245 - 253
  • [46] Loss of heterozygosity in benign, borderline and early malignant ovarian carcinoma
    Watson, RH
    Roy, WJ
    Davis, M
    Hitchcock, A
    Campbell, IG
    [J]. JOURNAL OF PATHOLOGY, 1996, 179 : A42 - A42
  • [47] Laparoscopic distal pancreatectomy for benign or borderline malignant pancreatic tumors
    Chung, Jun Chul
    Kim, Hyung Chul
    Song, Ok Pyung
    [J]. TURKISH JOURNAL OF GASTROENTEROLOGY, 2014, 25 : 162 - 166
  • [48] Upgrade of fibroepithelial lesions to phyllodes tumors: Benign, borderline, and malignant
    Chambers, Karinn
    Pradhan, Grishma
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 1) : 262 - 263
  • [49] The combined value of CA125 determination and echographic ovarian imaging, in preoperative diagnosis of benign, borderline and malignant ovarian tumors
    Stanculescu, R.
    Russu, M.
    Vladescu, T.
    Bausic, V.
    Teodorescu, A.
    [J]. GIORNALE ITALIANO DI OSTETRICIA E GINECOLOGIA, 2012, 34 (01): : 311 - 313
  • [50] Apoptosis in ovarian tumors (benign, borderline, malignant) and correlation with BCL-2 and P53 expression
    Dawamneh, MF
    Pau, J
    Attal, H
    Visscher, D
    Bedrossian, C
    [J]. LABORATORY INVESTIGATION, 1997, 76 (01) : 566 - 566